Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Nalin

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|July 5, 1980
Oral therapy with glucose electrolyte solutionM L Clements, M M Levine, R E Black, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agentsD L Shungu, D R Nalin, R H Gilman, et al.
Journal of Hepatology|February 1, 1997
Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adultsX Q Chen, M Bülbül, G C de Gast, et al.
Lancet (London, England)|October 21, 1978
Cannabis, hypochlorhydria, and choleraD R Nalin, M M Levine, J Rhead, et al.
Lancet (London, England)|May 27, 1978
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasiveM M Levine, E J Bergquist, D R Nalin, et al.
Journal of Medical Virology|July 1, 1996
Duration of protection from clinical hepatitis A disease after vaccination with VAQTAB L Wiens, N R Bohidar, J G Pigeon, et al.
Lipids|August 14, 2016
Biohydrogenation of cholesterol as an index of bacterial 7α-dehydroxylase activityC T Huang, M M Levine, W E Woodward, et al.
Lipids|September 1, 1981
Biohydrogenation of cholesterol as an index of bacterial 7 alpha-dehydroxylase activityC T Huang, M M Levine, W E Woodward, et al.
The Journal of Infectious Diseases|June 1, 1988
Use of norfloxacin to treat chronic typhoid carriersE Gotuzzo, J G Guerra, L Benavente, et al.
Lancet (London, England)|October 21, 1978
Cholera, non-vibrio cholera, and stomach acidD R Nalin, R J Levine, M M Levine, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|July 5, 1980
Oral therapy with glucose electrolyte solutionM L Clements, M M Levine, R E Black, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agentsD L Shungu, D R Nalin, R H Gilman, et al.
Journal of Hepatology|February 1, 1997
Immunogenicity of two versus three injections of inactivated hepatitis A vaccine in adultsX Q Chen, M Bülbül, G C de Gast, et al.
Lancet (London, England)|October 21, 1978
Cannabis, hypochlorhydria, and choleraD R Nalin, M M Levine, J Rhead, et al.
Lancet (London, England)|May 27, 1978
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasiveM M Levine, E J Bergquist, D R Nalin, et al.
Journal of Medical Virology|July 1, 1996
Duration of protection from clinical hepatitis A disease after vaccination with VAQTAB L Wiens, N R Bohidar, J G Pigeon, et al.
Lipids|August 14, 2016
Biohydrogenation of cholesterol as an index of bacterial 7α-dehydroxylase activityC T Huang, M M Levine, W E Woodward, et al.
Lipids|September 1, 1981
Biohydrogenation of cholesterol as an index of bacterial 7 alpha-dehydroxylase activityC T Huang, M M Levine, W E Woodward, et al.
The Journal of Infectious Diseases|June 1, 1988
Use of norfloxacin to treat chronic typhoid carriersE Gotuzzo, J G Guerra, L Benavente, et al.
Lancet (London, England)|October 21, 1978
Cholera, non-vibrio cholera, and stomach acidD R Nalin, R J Levine, M M Levine, et al.
Pageof 11